Clinical Trial Update: Second Echelon Node Study With Methylene Blue [NA]

View source ↗

Summary

A Mayo Clinic–sponsored trial evaluating methylene blue for second-echelon sentinel lymph node mapping in breast cancer and melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer, Melanoma | NA | Status: COMPLETED